TFSeB

Overview

TFSeB is an orally active neuroprotective agent. TFSeB can reduce Streptozotocin (STZ) ( HY-13753 ) induced MAO-B and AChE activity. TFSeB exerts neuroprotective effects by increasing the expression of BCL-2 , BDNF, NRF2, and decreasing the expression of BAX . TFSeB can reduce lipid peroxidation (TBARS) and reactive oxygen species (ROS) levels. TFSeB can reduce neuroinflammation. TFSeB can be used for research on Alzheimer’s disease.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Bcl-2 Family | Products > Signaling Pathways > Cholinesterase (ChE) | Products > Signaling Pathways > Monoamine Oxidase | Products > Signaling Pathways > Reactive Oxygen Species (ROS) | Products > Signaling Pathways > NF-κB

Product Information

• Catalog No.: HY-174419
• CAS No.: 3017240-62-6
• Molecular Formula: C16H13F3OSe
• Molecular Weight: 357.23
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source